GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » YoY EBITDA Growth

AngioDynamics (FRA:UG2) YoY EBITDA Growth : -259.32% (As of Feb. 2024)


View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. AngioDynamics's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was -259.32%.

AngioDynamics's EBITDA per Share for the three months ended in Feb. 2024 was €-0.09.


AngioDynamics YoY EBITDA Growth Historical Data

The historical data trend for AngioDynamics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics YoY EBITDA Growth Chart

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.27 -993.04 94.26 101.01 -24,400.00

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.90 -2,503.70 52.05 -100.92 -259.32

AngioDynamics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

AngioDynamics's YoY EBITDA Growth for the fiscal year that ended in May. 2023 is calculated as:

YoY EBITDA Growth (A: May. 2023 )
=(EBITDA per Share (A: May. 2023 )-EBITDA per Share (A: May. 2022 ))/ | EBITDA per Share (A: May. 2022 ) |
=(-0.486-0.002)/ | 0.002 |
=-24,400.00 %

AngioDynamics's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY EBITDA Growth (Q: Feb. 2024 )
=(EBITDA per Share (Q: Feb. 2024 )-EBITDA per Share (Q: Feb. 2023 )) / | EBITDA per Share (Q: Feb. 2023 )) |
=(-0.094-0.059)/ | 0.059 |
=-259.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AngioDynamics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of AngioDynamics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics (FRA:UG2) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

AngioDynamics (FRA:UG2) Headlines

No Headlines